Lab Matters Summer 2018 - Page 64

APHL 2018 Annual Meeting Poster Abstracts the conditions of this study. Qualification of additional RNA extraction procedures expands the options for domestic PHLs to use equipment already in place to perform testing for influenza. The data generated in this study supported FDA clearance of these two automated extraction platforms for influenza diagnostic testing using the CDC rRT-PCR Flu Panel. Presenter: LaSondra Berman, PhD, Centers for Disease Control and Prevention, Atlanta, GA, Phone: 404.639.1686, Email: zhj5@cdc.gov Incorporation of Non-Influenza Respiratory Virus Detections from the Public Health Laboratory Interoperability Project into the National Respiratory and Enteric Virus Surveillance System R. Dahl, A. Haynes, M. Prill and S. Gerber, US Centers for Disease Control and Prevention, Atlanta, GA National surveillance of non-influenza respiratory viruses (NIRVs) is essential to identify temporal and geographical trends for these pathogens in the US along with detecting re-emerging and novel viruses. Two national-level laboratory-based surveillance systems currently collect information on NIRVs. The CDC’s National Respiratory and Enteric Virus Surveillance System (NREVSS) monitors the circulation of respiratory viruses including adenoviruses, coronaviruses, enteroviruses, metapneumovirus, parainfluenza viruses, respiratory syncytial virus and rhinoviruses through voluntary reporting of antigen, culture and PCR diagnostic test data primarily from university, hospital and commercial laboratories. NREVSS collects weekly aggregate counts of tests, typically via manual entry, which does not allow for more detailed analyses of respiratory virus activity due to a lack of specimen-level epidemiologic data. The Public Health Laboratory Interoperability Project (PHLIP) and Public Health Lab Information System replacement (PHLIS2) are two mechanisms by which state and local health laboratories (PHLs), plus several other non-commercial laboratories, can report to CDC for the purposes of conducting influenza surveillance. It also routinely receives specimen-level NIRV testing results. Specimen-level test results along with descriptive patient information are reported automatically to CDC and these data allow for detection of co-infections and more refined epidemiologic character ^][ۈ[\XH]Uˈ[[YܝX[[[H&\]H\\YXH&H\ܝ[˜\[[[[H\Y[Z[X\X]KH]\[ۈو\[\X\\  H[[Y[H]\[ۈ Q H\HXܘ][š[ܙX\H\ܝ[وX[Y[[][T]HXHT܈T̂[[ܜܘ]H\H]H[Uˈ\ ]\Z[HYT]H\H\X]H܈[\[ۈ[U]HH\]\ܝY\[\\H\\Y܈\\X[]K^ [ LHY][ۘ[\ܝ[T܈T̈]؝\T\\[\[H\ܝ[U\B\Y\HZ\]H][ݚYHHXۙ\B\Hو]H[Y]HHY\Y\ˈ]K\[Y]Y]HH\H MHX[[\H\ܝ[Z\X[Y[B][]HU^\][HYT܈T̋]\[[ܙHX\H\[H[\[[Y][ۈX[ ܂\ܘY[Z\Y\Y[\[\[YHT\\[[Z\T܈T̈[Z\[ۜˈXܘ][ۜ]XZH\ܝ[Y][ܙHYXY[[[H[][ۜ\]Y[[\X\][Xܘ]ܚY\[\X[\]B[[XXX[\\Y[[XZ[Z[H؝\\Z[[H\[N[[[X][H۝X]\H]\PPUT[[Y\ N[\[[و\[\\]ܞH\X\H[[HT˂\[\XXHZ T[\܈\X\H۝[][[ۋ][KK[XZ[]M˙݂][Y[وH\]Y\\]Y[[\XY[YB[\X\^H][[\\]ܞHX[Y[B[^Z[Y\\]ܞH\X\H]XZ\ۜ\“KX^ H K[]^ H  H ˔ˈ[ܚ\ۈ H  [ ˂[Y\ ˈ]H  Y ˈ[K[[ H HT[\™܈\X\H۝[][[ۋ][KK X\X\]‘\\Y[وXXX[ ۋPK Z[\H\\Y[وX[  ][ S\YY[YX][ۈو][H\ܚ]X[\[\\]ܞB]XZ[X\H\]Y[\[[ۜX^HHYX]H܂[[\X\H[Z\[ۋH[^Z[Y\\]ܞH\X\B]XZ THܚ[ܛ\]HT[\܈\X\B۝[][[ۈ HݚY\Xܘ]ܞH[\Y[Z[Xœ\ܝXXX[Xܘ]ܚY\\[\\]ܞH\X\B]XZ[\Y][ۜˈ[H K][H[\[Y[][ۈقH\SX[\^H\ PKHZXܛٛZYXX[ ][YHԈ\^B܈][K\][]X[ۋ\[\ݙY[YH\[[[ܙX\YHܝ[ۈو]XZ[XHؘXH][B\Y[YYYݙ\ L K[ [][H[XZ[[\]H[X[B]XZ[\Y][ۜ[[[YYX]H\[\H[Z]Yœ][]X[ۋ\\\[\\]Z\Y[ܙ\Y[YBX]\\]X^H\XX[][ۈX[Y[][ۜ\ܚX[œXX\܈\H]X][ۋ^[\ۈ^\[Xܘ]ܞB\[\X]K[ۙ]Z[\H[X\X\]œ]HXXX[Xܘ]ܚY\  K]H][YH\]Y\\]Y[[\X][X\[][[[\][]X[ۈ[\X\^][ۋX\[X[X[[]\[\\[H]\Z[[܈Z[\\ˈ\HY۝X[Y\˜\H\Y[\]H\]Y[K\XYH[\XۈX\Y\܈^ B[\][ۈ\]Y[[ ZT\JH[[\\ˈXX]H\۝X]YH[[و\^\YY۝X[YH\Yۋ\ܛX[B\\Y[[ܛY][X][ۈو\^\\YۙYHH\]\ˈ]\H]H][Y H[\^\܈Y[YX][ۂ KZ[\[ M K܈[[ZXܛؚX[\\[H]\Z[][ۂ K܈[\^\H\[Z]و]X[ۈ\\]Z][[܂\\[܈Hܜ\ۙ[X[ ][YHԈ\^H\ܛYYۂPˈ[\Z[]H\ܛX[H][X][ۈ[MB[]HܛX] \^\\H][X]Y܈\ܛX[HۈB[ٛZYX\\[H Y\[X\\ Z\H[[ˊK\[وH[[و [X[Y[[M][]H]PB[S \[\ۈHX\\]HX[YX\\&\™X[]HZY[Y[Z[\\[ˈ[][ZY[XX[\H\H]XYHXX]H[ܛX][XX\HB^XY[\Xۈ\\YNL HوXݙ\YX[Y\]Y[BXYˈ][\H]H[[\\]YY\[Y[HXY[Y\\YY]\H\\YX^[Z^HX\XBوXYY[YX][ۋZ[[Z^H\][[YH[\\B]\[K[\[\X[ˈ[Y[Y[و]HXܘ]ܚY\š\[Y[ܙX\H[ZX[[ܛX]X\X]H]YB[[ۘ[]X^H\H\Y[ۘ[[\܈]\HTš[\Y][ۜˈ\Z[]HY[ۘ[Xܘ]ܞH\[X^B[\ݙH]\Z[][ۈو][HHYX[H[YHH[\BX[ۈ\[˂XXX[XTT ܙ